Our recent partnership with @AlcamiNow will help us develop safe and controlled oral delivery methods for our proprietary psilocybin. We expect to manufacture our initial batch of cGMP psilocybin API in September. https://twitter.com/TrypTherapeutic/status/1401902107431735311?s=20